Literature DB >> 16931287

Adaptive and innate immune reactions regulating mast cell activation: from receptor-mediated signaling to responses.

Christine Tkaczyk1, Bettina M Jensen, Shoko Iwaki, Alasdair M Gilfillan.   

Abstract

In this article, we have described studies that have demonstrated that mast cells can be activated as a consequence of adaptive and innate immune reactions and that these responses can be modified by ligands for other receptors expressed on the surface of mast cells. These various stimuli differentially activate multiple signaling pathways within the mast cells required for the generation and/or release of inflammatory mediators. Thus, the composition of the suite of mediators released and the physiologic ramifications of these responses are dependent on the stimuli and the microenvironment in which the mast cells are activated. Knowledge of the different signaling molecules used by cell surface receptors may allow selective pharmacologic targeting such that inhibiting the adverse effects of mast cell activation can be achieved without influencing the beneficial effects of mast cell activation. The exact interconnections between the signaling pathways initiated by the surface receptors described in this article remain to be completely worked out; thus, this remains a topic for future investigation.

Mesh:

Substances:

Year:  2006        PMID: 16931287     DOI: 10.1016/j.iac.2006.05.011

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  12 in total

Review 1.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

2.  'Renal hypersensitivity' to inulin and IgA nephropathy.

Authors:  Justine Bacchetta; Florence Villard; Thierry Vial; Laurence Dubourg; Raymonde Bouvier; Behrouz Kassaï; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

Review 3.  The role of eosinophils and mast cells in intestinal functional disease.

Authors:  Marjorie M Walker; Alasdair Warwick; Chuin Ung; Nicholas J Talley
Journal:  Curr Gastroenterol Rep       Date:  2011-08

4.  TLR-mediated signaling pathways circumvent the requirement for DAP12 in mast cells for the induction of inflammatory mediator release.

Authors:  Daniel Smrz; Shoko Iwaki; Daniel W McVicar; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  Eur J Immunol       Date:  2010-11-11       Impact factor: 5.532

Review 5.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 6.  Amplification mechanisms for the enhancement of antigen-mediated mast cell activation.

Authors:  Alasdair M Gilfillan; Richard D Peavy; Dean D Metcalfe
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

7.  Src-like adaptor protein (SLAP) is upregulated in antigen-stimulated mast cells and acts as a negative regulator.

Authors:  Seung-Kiel Park; Huihong Qiao; Michael A Beaven
Journal:  Mol Immunol       Date:  2009-04-15       Impact factor: 4.407

Review 8.  New roles for mast cells in modulating allergic reactions and immunity against pathogens.

Authors:  Alison M Hofmann; Soman N Abraham
Journal:  Curr Opin Immunol       Date:  2009-10-12       Impact factor: 7.486

Review 9.  Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

Authors:  B M Jensen; C Akin; A M Gilfillan
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

10.  Modulation of mast cell proliferative and inflammatory responses by leukotriene d4 and stem cell factor signaling interactions.

Authors:  Nosayba Al-Azzam; Vinay Kondeti; Ernest Duah; Farai Gombedza; Charles K Thodeti; Sailaja Paruchuri
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.